Citations

Showing 10 of 108048 citations.

Functional role of glial-derived neurotrophic factor in a mixed allergen murine model of asthma
Drake, Li Y. , Wicher, Sarah A. , Roos, B., Khalfaoui, Latifa, Nesbitt, Lisa, Pabelick, Christina M. , Prakash, Y. S. , Roos, Benjamin B, Pabelick, Christina M , Prakash, Y S , Drake, Li , Fang, Yun Hua

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | November 21, 2023 | Volume: 326 | Issue: 1 | Pages: L19-L28

10.1152/ajplung.00099.2023 | PMID 37987758 Get It

Local production of growth factors within the airway with autocrine/paracrine effects can promote features of asthma. Here, we show that glial-derived neurotrophic factor (GDNF) is a procontractile and proremodeling factor that contributes to allergen-induced airway hyperreactivity and tissue remodeling in a mouse model of asthma. Blocking GDNF signaling attenuates allergen-induced airway hyperreactivity and remodeling, suggesting a novel approach to alleviating structural and functional changes in the asthmatic airway.
Exogenous hydrogen sulfide attenuates hyperoxia effects on neonatal mouse airways
Bartman, Colleen M. , Schiliro, Marta, Nesbitt, Lisa, Lee, Kenge K., Prakash, Y. S. , Pabelick, Christina M. , Prakash, Y S , Pabelick, Christina M , Bartman, Colleen M

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | November 21, 2023 | Volume: 326 | Issue: 1 | Pages: L52-L64

10.1152/ajplung.00196.2023 | PMID 37987780 Get It

Chronic airway disease is a short- and long-term consequence of premature birth. Understanding effects of O2 exposure during the perinatal period is key to identify targetable mechanisms that initiate and sustain adverse airway changes. Our findings show a beneficial effect of exogenous H2S on developing mouse airway structure and function with notable sex differences. H2S donors alleviate effects of O2 on airway hyperreactivity, contractility, airway smooth muscle thickness, and extracellular matrix deposition.
The Brief Case: An unexpected cause of meningoencephalitis in an infant
Shirley, Joshua D. , Ngo, Tiffany T., Patel, Jenny A. , Pritt, Bobbi S. , Gaensbauer, James , Theel, Elitza S. , Gaensbauer, James T , Pritt, Bobbi S , Ngo, Tiffany

Mayo Clinic

Journal of Clinical Microbiology | November 21, 2023 | Volume: 61 | Issue: 11 | Pages: No page available

10.1128/jcm.01856-22 | PMID 37987733 Get It

Clival ectopic pituitary prolactinoma was successfully managed by transsphenoidal surgery: A rare case report
Mansour, Marah , Khozamah, Zeinah, Naksho, Abdulmonem , Zayat, Roaa , Sabbagh, Aliaa Al, Deeb, Ahmad

Mayo Clinic

Clinical Case Reports | November 21, 2023 | Volume: 11 | Issue: 11 | Pages: No page available

10.1002/ccr3.8255 | PMID 38028100 Get It

Key Clinical MessageEctopic pituitary adenoma is a rare neoplasm located in the clivus and could mimic other clival tumors. Diagnosis and treatment could be challenging. It should be considered in the differential diagnosis of clival tumors.AbstractEctopic pituitary adenomas (EPAs) are isolated adenomas that can be located in variable locations outside the sella turcica and have a normal‐appearing pituitary gland. These tumors are rare and are thought to often arise from embryological remnants along the route of Rathke's pouch migration. EPAs are associated with a wide range of clinical manifestations depending on hormonal activity and involvement of adjacent structures, which can represent a challenge in making the diagnosis and deciding on the most appropriate management. In this case study, we report a 47‐year‐old male who presented with visual disturbances, a headache, and generalized weakness. Magnetic resonance imaging showed a 2 cm mass located in the clivus invading the sphenoid sinus with an intact pituitary gland. The patient underwent endoscopic transsphenoidal surgery to eradicate the mass while maintaining the integrity of the pituitary gland, which was successful and uneventful. Pathological studies were consistent with prolactinoma, with no cytological malignant features. Post‐surgery, symptoms notably improved, and serum prolactin levels significantly dropped, The patient's condition was satisfactory on follow‐up with no long‐term complications reported. This paper contributes to the existing literature by sharing the clinical management of a challenging and uncommon case.
Reply to Comment on “Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions”
Chen, Austin D. , Lin, Samuel J. , Chi, David

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | November 21, 2023 | Volume: 11 | Issue: 11 | Pages: e5258

10.1097/gox.0000000000005258 | PMID 38025632 Get It

Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration
Liu, Arthur , Pisaneschi, Federica , Boda, Akash R. , Ager, Casey R. , Piwnica‐Worms, David , Hong, David S. , Curran, Michael A. , Hong, David S , Curran, Michael A , Piwnica-Worms, David , Pisaneschi, Federica , Liu, Arthur J , Gammon, Seth T

Mayo Clinic

JCI Insight | November 21, 2023 | Volume: 9 | Issue: 1 | Pages: No page available

10.1172/jci.insight.169150 | PMID 37988164 Get It

We previously showed that ablation of tumor hypoxia can sensitize tumors to immune checkpoint blockade (ICB). Here, we used a Kras +/G12D TP53 +/R172H Pdx1-Cre –derived (KPC-derived) model of pancreatic adenocarcinoma to examine the tumor response and adaptive resistance mechanisms involved in response to 2 established methods of hypoxia-reducing therapy: the hypoxia-activated prodrug TH-302 and vascular endothelial growth factor receptor 2 (VEGFR-2) blockade. The combination of both modalities normalized tumor vasculature, increased DNA damage and cell death, and delayed tumor growth. In contrast with prior cancer models, the combination did not alleviate overall tissue hypoxia or sensitize these KPC tumors to ICB therapy despite qualitative improvements to the CD8 + T cell response. Bulk tumor RNA sequencing, flow cytometry, and adoptive myeloid cell transfer suggested that treated tumor cells increased their capacity to recruit granulocytic myeloid-derived suppressor cells (G-MDSCs) through CCL9 secretion. Blockade of the CCL9/CCR1 axis could limit G-MDSC migration, and depletion of Ly6G-positive cells could sensitize tumors to the combination of TH-302, anti–VEGFR-2, and ICB. Together, these data suggest that pancreatic tumors modulate G-MDSC migration as an adaptive response to vascular normalization and that these immunosuppressive myeloid cells act in a setting of persistent hypoxia to maintain adaptive immune resistance.
Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech
Pham, Nha Trang Thu, Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Tetzloff, Katerina A. , Duffy, Joseph R. , Clark, Heather M. , Machulda, Mary M. , Botha, Hugo , Jack, Clifford R. , Dickson, Dennis W. , Utianski, Rene L.

Mayo Clinic

Journal of Alzheimer's Disease | November 21, 2023 | Volume: 96 | Issue: 4 | Pages: 1759-1765

10.3233/jad-230912 | PMID 38007664 Get It

Background: The agrammatic variant of primary progressive aphasia (PAA), primary progressive apraxia of speech (PPAOS), or a combination of both (AOS-PAA) are neurodegenerative disorders characterized by speech-language impairments and together compose the AOS-PAA spectrum disorders. These patients typically have an underlying 4-repeat tauopathy, although they sometimes show evidence of amyloid-β and tau deposition on PET, suggesting Alzheimer’s disease (AD). Given the growing number of pharmacologic treatment options for AD, it is important to better understand the incidence of AD pathology in these patients. Objective: This study aimed to evaluate the frequency of amyloid-β and tau positivity in AOS-PAA spectrum disorders. Sixty-five patients with AOS-PAA underwent a clinical speech-language battery and PiB PET and flortaucipir PET imaging. Methods: Global PiB PET standardized uptake value ratios (SUVRs) and flortaucipir PET SUVRs from the temporal meta region of interest were compared between patient groups. For 19 patients who had died and undergone autopsy, their PET and pathology findings were also compared. Results: The results showed that although roughly half of the patients are positive for at least one biomarker, their clinical symptoms and biomarker status were not related, suggesting that AD is not the primary cause of their neurodegeneration. All but one patient in the autopsy subset had a Braak stage of IV or less, despite four being positive on tau PET imaging. Conclusions: Inclusion criteria for clinical trials should specify clinical presentation or adjust the evaluation of such treatments to be specific to disease diagnosis beyond the presence of certain imaging biomarkers.
Voxel-Wise Comparison of Co-Registered Quantitative CT and Hyperpolarised Gas Diffusion-Weighted MRI Measurements in IPF
Chan, Ho‐Fung , Weatherley, Nicholas , Biancardi, Alberto , Johns, Christopher S., Karwoski, Ronald A., Bartholmai, Brian J. , Bianchi, Stephen , Wild, Jim M. , Bartholmai, Brian J , Wild, Jim M , Johns, Christopher , Tahir, Bilal

Mayo Clinic

Diagnostics | November 21, 2023 | Volume: 13 | Issue: 23 | Pages: 3497

10.3390/diagnostics13233497 | PMID 38066737 Get It

The patterns of idiopathic pulmonary fibrosis (IPF) lung disease that directly correspond to elevated hyperpolarised gas diffusion-weighted (DW) MRI metrics are currently unknown. This study aims to develop a spatial co-registration framework for a voxel-wise comparison of hyperpolarised gas DW-MRI and CALIPER quantitative CT patterns. Sixteen IPF patients underwent 3He DW-MRI and CT at baseline, and eleven patients had a 1-year follow-up DW-MRI. Six healthy volunteers underwent 129Xe DW-MRI at baseline only. Moreover, 3He DW-MRI was indirectly co-registered to CT via spatially aligned 3He ventilation and structural 1H MRI. A voxel-wise comparison of the overlapping 3He apparent diffusion coefficient (ADC) and mean acinar dimension (LmD) maps with CALIPER CT patterns was performed at baseline and after 1 year. The abnormal lung percentage classified with the LmD value, based on a healthy volunteer 129Xe LmD, and CALIPER was compared with a Bland–Altman analysis. The largest DW-MRI metrics were found in the regions classified as honeycombing, and longitudinal DW-MRI changes were observed in the baseline-classified reticular changes and ground-glass opacities regions. A mean bias of −15.3% (95% interval −56.8% to 26.2%) towards CALIPER was observed for the abnormal lung percentage. This suggests DW-MRI may detect microstructural changes in areas of the lung that are determined visibly and quantitatively normal by CT.
Paediatric trigger fingers: a 47-year experience
Wan, Rou , Sarcon, Aida K. , Pino, Paula A. , Mundell, Benjamin F. , Zhao, Chunfeng , Moran, Steven L. , Pommer, Paula Pino

Mayo Clinic

Journal of Hand Surgery (European Volume) | November 21, 2023 | Volume: 49 | Issue: 8 | Pages: 1023-1029

10.1177/17531934231214103 | PMID 37987675 Get It

Paediatric trigger finger is rare compared to adult trigger finger or paediatric trigger thumb, and the aetiology is unclear. Proposed causes include local trauma, anatomical anomalies and systemic conditions. The aim of the present study was to detail the anatomical causes of surgically treated paediatric trigger fingers and provide an operative algorithm based on the anatomical findings. A total of 76 trigger fingers in 38 patients were identified retrospectively at our institution between 1975 and 2022. In total, 41 fingers in 26 patients had anatomical variations. A nodular thickening on the tendon, similar to Notta’s nodule in trigger thumbs, was the most common anatomical cause. Abnormal decussation of the flexor digitorum superficialis tendon was the second most common variation. The recurrence rate was significantly lower after resection of one slip of the flexor digitorum superficialis tendon compared to other surgical techniques in these patients. We recommend that surgeons assess for possible anatomical variation during surgery for the trigger finger. Level of evidence: IV
Impact of Successful Recanalization and Clinical Outcomes of Patients With Acute Ischemic Stroke with 5 or More Thrombectomy Passes
Uchida, Kazutaka , Kasab, Sami Al , Maier, Ilko , Jabbour, Pascal , Kim, Joon‐Tae , Rai, Ansaar , Starke, Robert M. , Psychogios, Marios‐Nikos , Grossberg, Jonathan A , Tanweer, Omar , Polifka, Adam , Park, Min S. , Brinjikji, Waleed , Moss, Mark, Williamson, Richard , Navía, Pedro , Kan, Peter , Chowdhry, Shakeel , Ezzeldin, Mohamad , Spiotta, Alejandro M , Collaborators, for the Stroke Thrombectomy and Aneurysm Registry (STAR), Navia, Pedro , Sowlat, Mohammad‐Mahdi , Matsukawa, Hidetoshi , Elawady, Sameh Samir , Alawieh, Ali , Cunningham, Conor M. , Jabbour, Pascal , Wolfe, Stacey Q , Shaban, Amir , Arthur, Adam Stephen , Cuellar, Hugo , Romano, Daniele G., Mascitelli, Justin R , Fragata, Isabel , Osbun, Joshua W , Crosa, Roberto , Matouk, Charles , Levitt, Michael R. , Leacy, Reade De , Yoshimura, Shinichi , Collaborators, for the Stroke Thrombectomy and Aneurysm Registry (STAR)

Mayo Clinic

Stroke: Vascular and Interventional Neurology | November 21, 2023 | Volume: 4 | Issue: 1 | Pages: No page available

10.1161/svin.123.001107 | PMID 41586058 Get It

Background As the number of thrombectomy passes increases during endovascular therapy (EVT) for acute stroke, neurointerventionalists must weigh the risks of potential complications against the risk of failing to recanalize the affected vessel. Thus, we investigated the effectiveness and safety of EVT for patients with acute stroke in which ≥5 EVT passes were performed. Methods This retrospective cohort study from January 2013 to December 2022 included 31 thrombectomy‐capable centers. Patients in whom ≥5 EVT passes were made were included in the analysis. The patients with successful recanalization defined as modified Thrombolysis in Cerebral Infarction ≥2b at 5, 6, 7, or more passes were compared with unsuccessful recanalization. We also compared procedure time, separated by 30 minutes. Primary outcome was a favorable 90‐day outcome (modified Rankin scale score of 0–2). Secondary outcomes were intracranial hemorrhage and death. Results A total of 407 patients met the inclusion criteria, of which 175 were women (43.1%); the mean age was 67.3 years. In 265 (65.1%) patients, successful recanalization was achieved: 134 patients with 5 passes, 67 patients with 6 passes, and 64 with ≥7 passes. Intravenous recombinant tissue plasminogen activator administration was more common in the unsuccessful recanalization group (successful recanalization with 5, 6, and ≥7 EVT passes and unsuccessful recanalization: 35.3%, 30.3%, 18.8%, and 45.4%, respectively). Successful recanalization with 5, 6, and ≥7 EVT passes was associated with favorable outcome compared with unsuccessful recanalization group (adjusted odds ratio successful recanalization with 5, 6, and ≥7 EVT passes to unsuccessful recanalization [95% CIs]: 8.29 [2.13–32.3]; 14.0 [3.27–60.3]; and 5.26 [1.12–24.8], respectively). However, symptomatic intracranial hemorrhage was not significantly different between the groups. Regarding procedure time, favorable outcome was not significantly different in each group, while symptomatic intracranial hemorrhage occurred more frequently in the 60 to 89 minutes group compared with the <30 minutes group (adjusted odds ratio, 60–89 minutes group to <30 minutes group [95% CI]: 5.86 [1.09–31.6]). Conclusion These findings suggest that a benefit in outcome persists for recanalization, without significant increase in complications. In addition, there was no significant difference in favorable outcomes among procedure time.